PKI PerkinElmer Inc.

PerkinElmer to Hold Earnings Call on Thursday, August 3, 2017

PerkinElmer, Inc., (NYSE:PKI) a global leader committed to innovating for a healthier world, today announced that on Thursday, August 3 2017, after market close, the Company will release second quarter 2017 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert Friel, chairman and chief executive officer, and Andy Wilson, senior vice president and chief financial officer, will host the conference call.

To access the call, please dial (541) 797-2422 prior to the scheduled conference call time and provide the access code 48363672. A live audio webcast of the call will also be available on the Investors section of the Company’s Web site at www.perkinelmer.com.

A replay of the webcast will be available beginning at 7:00 p.m. ET, Thursday, August 3, 2017 through the Investors section of the Company’s Web site at www.perkinelmer.com.

About PerkinElmer

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of 9,000 employees worldwide are passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets. Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us. The Company reported revenue of approximately $2.1 billion in 2016, serves customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

EN
10/07/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PerkinElmer Inc.

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Revvity, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 24 June 2025 in which we reassessed the appropriateness of the ratings in the context of the ...

 PRESS RELEASE

Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with N...

WALTHAM, Mass.--(BUSINESS WIRE)-- (NYSE: RVTY), announced today that its business has launched the (CE-IVDR), an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics. Now available in countries accepting the CE mark, this all-in-one solution increases the efficiency of the entire IIFT process, encompassing sample preparation, incubation, washing and mounting of slides as well as image acquisition and analysis. “Traditional IIFT processing can be tedious and time-consuming, requiring the expertise of specially trained lab technicians and a dark room,”...

PerkinElmer, Inc. - January 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

PerkinElmer, Inc. - October 2022 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

PerkinElmer, Inc. - July 2022 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch